Promising drug targets obesity caused by brain damage
NCT ID NCT05774756
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study tests a daily injection called setmelanotide to help people aged 4 and older who gained weight after a brain injury (hypothalamic obesity). The goal is to see if it reduces body weight, hunger, and improves quality of life over 52 weeks. Half of the 143 participants will get the drug, half a placebo, and neither they nor their doctors will know which they receive.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED HYPOTHALAMIC OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ann and Robert H. Lurie Children's Hospital
Chicago, Illinois, 60611, United States
-
Birmingham Women and Children's Hospital NHS Trust
Birmingham, B46NH, United Kingdom
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Children's Minnesota
Saint Paul, Minnesota, 55102, United States
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
-
Hull University Teaching Hospital
Hull, HU32RW, United Kingdom
-
Icahn School of Medicine at Mount Sinai
New York, New York, 100029, United States
-
Lynn Health Science Institute
Oklahoma City, Oklahoma, 73122, United States
-
Medicover Neuroendokrinologie
München, 81667, Germany
-
Nagano Children's Hospital
Azumino, Nagano, 399-8288, Japan
-
Nagoya City University Hospital
Nagoya, Aichi-ken, 467-8602, Japan
-
Ohio State Wexner Medical Center
Columbus, Ohio, 43203, United States
-
Prinses Maxima Center for Pediatric Oncology
Utrecht, 3584CS, Netherlands
-
Rady Children's Hospital
San Diego, California, 92123, United States
-
Seattle Children's Hospital, Research and Foundation - Center for Integrative Brain Research
Seattle, Washington, 98101, United States
-
Toranomon Hospital
Minato, Tokyo, 105-8470, Japan
-
UAN Pediatric Endocrinology
Birmingham, Alabama, 35233, United States
-
UCL Great Ormond Street Institute of Child Health
London, WC1N 1EH, United Kingdom
-
Universitaetsklinikum Hamburg-Eppendorf (UKE) - Ambulanzzentrum des UKE GmbH
Hamburg, 20246, Germany
-
Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin
Ulm, 89075, Germany
-
University Children's Hospital, Klinikum Oldenburg
Oldenburg, 26133, Germany
-
University of Florida
Gainesville, Florida, 32610-0296, United States
-
University of Iowa Stead Family Department of Pediatrics
Iowa City, Iowa, 52242, United States
-
Vanderbilt University School of Medicine
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a diabetes drug tame obesity caused by brain tumor treatment?
- New pill targets hard-to-treat obesity after brain injury
- Could a diabetes drug help teens with rare obesity syndromes shed pounds?
- New weekly shot aims to curb obesity in rare genetic disorders
- New hope for hypothalamic obesity: Long-Term drug trial launches
- Hope for hypothalamic obesity: daily shot targets weight and hunger